Rare variant density across the genome and across populations
© Raska and Zhu; licensee BioMed Central Ltd. 2011
Published: 29 November 2011
Skip to main content
Volume 5 Supplement 9
© Raska and Zhu; licensee BioMed Central Ltd. 2011
Published: 29 November 2011
Next-generation sequencing allows for a new focus on rare variant density for conducting analyses of association to disease and for narrowing down the genomic regions that show evidence of functionality. In this study we use the 1000 Genomes Project pilot data as distributed by Genetic Analysis Workshop 17 to compare rare variant densities across seven populations. We made the comparisons using regressions of rare variants on total variant counts per gene for each population and Tajima’s D values calculated for each gene in each population, using data on 3,205 genes. We found that the populations clustered by continent for both the regression slopes and Tajima’s D values, with the African populations (Yoruba and Luhya) showing the highest density of rare variants, followed by the Asian populations (Han and Denver Chinese followed by the Japanese) and the European populations (CEPH [European-descent] and Tuscan) with the lowest densities. These significant differences in rare variant densities across populations seem to translate to measures of the rare variant density more commonly used in rare variant association analyses, suggesting the need to adjust for ancestry in such analyses. The selection signal was high for AHNAK, HLA-A, RANBP2, and RGPD4, among others. RANBP2 and RGPD4 showed a marked difference in rare variant density and potential selection between the Luhya and the other populations. This may suggest that differences between populations should be considered when delimiting genomic regions according to functionality and that these differences can create potential for disease heterogeneity.
Genome-wide association studies have proven to be successful in identifying some of the common variants that contribute to complex disease. Nevertheless, most of the variation underlying complex disease has yet to be discovered. Focus is starting to shift toward capturing other types of variation. The new next-generation sequencing technology allows for the identification of rare variants across many individuals and for their use in studies of association to disease. This new technology also allows for the study of patterns of sequence variation that can point to functional regions in the genome, which can then be targeted in candidate gene and pathway association analyses. Incorporating a priori knowledge about functionality across genomic regions lowers the number of association tests conducted in the usual genome-wide association studies, thereby increasing their power.
Rare variant association analysis can be conducted under the premise that rare variants are deleterious and that their presence in individuals increases risk of disease. Several approaches to comparing counts of rare variants between case and control subjects have been proposed, including individual- and group-based measures of diversity [1, 2]. One such measure could be the number of rare variants for the group relative to the total number of polymorphic sites. Differences between populations in the genome-wide density of rare variants can confound rare variant association analysis, and such differences between populations have yet to be described.
Rare variant density can also be used to narrow down the functional regions within the genome. Neutrality theory suggests that most mutations are selectively neutral; that is, the allele frequency distribution observed for a population is the result of a balance between the acquisition of new mutations and the loss of mutations as a result of genetic drift . Tajima’s D is one common measure used to gauge excess or deficiency of rare variants under the null model of neutral evolution . Populations that differ in their environmental histories and that present some genome-wide divergence (and therefore different genomic contexts) can vary with respect to the regions or genes that undergo selection . These differences may be relevant for studies that attempt to incorporate regional genomic functionality into the study’s design.
In this paper we look at the patterns of rare variant density across the genome using the sequencing data obtained by the 1000 Genomes Project  and distributed by Genetic Analysis Workshop 17 (GAW17) for 3,205 genes across seven populations: CEPH (a European-descent population from Utah) (n = 90), Denver Chinese (n = 107), Han Chinese (n = 109), Japanese (n = 105), Luhya (n = 108), Tuscan (n = 66), and Yoruba (n = 112). We examine differences in rare variant distribution between populations and discuss their implications for rare variant association analysis and for inferring genome region functionality.
Rare variant counts (single-nucleotide polymorphisms [SNPs] with minor allele frequencies [MAFs] less than 0.05) and total variant counts (total number of SNPs) are calculated for each of the 3,205 genes (i = 1:3,205) for each population individually and for the seven populations pooled (j = 1:8). A linear regression between these two measures gives an estimate for the slope B, which characterizes their relationship:
Rare variants (i, j) = B(j) × Total variants (i, j) + e(i, j). (1)
The same analysis is carried out using synonymous and nonsynonymous SNPs separately.
The Yoruba and CEPH populations are contrasted with respect to their rare variant density across individuals. The proportion of individuals with rare variants is computed for each of the 3,205 genes as the number of individuals who have at least one rare variant for the gene for their population divided by the total number of individuals in the population. The average number of rare variants per individual for each of the genes is computed by summing the number of rare variants present in each individual for the gene and dividing by the total number of individuals in the population. A paired t test is used to compare the two populations.
The variance of the difference between these two measures is computed as described by Tajima .
Our analysis was made using nonsynonymous and synonymous SNPs separately. All computations were carried out through programming with R software using its standard base packages.
Rare variant density and values of Tajima’s D across populations
Mean Tajima’s D
3.30 × 10−15 a
5.90 × 10−3 a
6.60 × 10−8 a
9.33 × 10−1
1.30 × 10−3 a
8.80 × 10−2
<2.2 × 10−16 a
For the pooled analysis, we found that the outlying genes were AHNAK, which had the greatest number of rare variants per total number of variants compared to other genes, and CDC27, PRR4, and HLA-A, which had the least number of rare variants per total number of variants.
The rare variant to total variant slopes and Tajima’s D values for the nonsynonymous and synonymous SNPs group the populations in a similar way (see Table 1). The Tuscan and CEPH populations present the lowest density of rare variants, with their lower slope values and higher D means, followed by the Japanese population. The Chinese populations present an intermediate value, and the African Yoruba and Luhya populations have the highest slopes and most negative D values.
Statistics aggregated across populations
Mean Tajima’s D
Variance of Tajima’s D
Total number of variants
Proportion of rare variants
Proportion of rare variants that are nonsynonymous
RANBP2 stands out as an exception to the consistency in values of Tajima’s D across populations in the nonsynonymous SNPs analysis. Excluding the Luhya population, the average number of total variants across the remaining populations is 28.5. Ninety-five percent of these variants are rare, and 75% of these rare variants are nonsynonymous. The Luhya population, on the other hand, has only one common variant for RANBP2. A similar pattern is observed for RGPD4, where the mean number of total variants is 21.5 excluding the Luhya. Eighty-five percent of these are rare, and 64% of these rare variants are nonsynonymous. The Luhya population has only three segregating sites for RGPD4, two of which are rare variants.
When comparing rare variant density between populations, investigators want to know whether the differences are due to drift or selection. For instance, values of Tajima’s D that are less than −2 may indicate positive selection, whereas values greater than 2 may provide evidence of balancing selection. But, under neutral theory, selection can be inferred from Tajima’s D only if a balance between the mutation rate and the rate of allelic fixation is assumed. This balance does not exist if the population is going through a period of expansion or contraction—demographic phenomena that can also result in negative and positive values of Tajima’s D, respectively—instead of selection. One way to distinguish between demography and selection is that demography affects the genome as a whole, whereas selection has a differential effect on functional regions within the genome.
Rare variant to total variant regression across the 3,205 genes distributed throughout the genome averages out the differential effects of selection. Slope differences between populations are a better reflection of the differences in demographic phenomena that affect all genes for each population. Populations group by continent for this parameter, with the African, European, and Asian populations showing slopes with more similar values within continents. The Japanese population is significantly different from both the European and the Chinese populations. Mean values of Tajima’s D for each population for both synonymous and nonsynonymous SNPs group the populations in the same manner, with the African populations showing the greatest density of rare variants. Note that this does not simply indicate higher and lower levels of overall variation but rather higher and lower levels of rare variants given the amount of total variation. Although the African populations have been known to harbor greater overall variation, they may also present greater levels of rare variants, even after taking their overall level of variation into account. In a study of one of the most sequenced genes in humans, BRCA1, individuals with African ancestry were shown to have a significantly higher proportion of deleterious mutations compared to European Americans . It would be of interest to see whether this is a result that is specific to this particular gene or whether it is product of the demography of the African population, as suggested by this study, and thereby reflected genome-wide. With the advent of more affordable sequencing technologies, the answer to this question can be pursued and may aid in the study of the genetic epidemiology of cancer and health disparities.
The outlier genes highlighted in Figure 1 are likely to represent instances of selection because their rare variant loads are distinct from that of other genes and is unlikely to be due to demographic parameters. AHNAK, which lies above the regression line, presents an excess of rare variants compared to other genes and is likely under positive selection; CDC27, PRR4, and HLA-A are under the regression line, which means that they present an excess of common variants and are likely under balancing selection. The AHNAK gene encodes an unusually large protein that is typically repressed in cell lines derived from human neuroblastomas and in several other types of tumors. AHNAK is known to be composed of highly conserved repeated elements . Regions in the genome that are highly conserved are generally so because of the selective pressure acting on them. At the other end of the spectrum lies the human leukocyte antigen system (HLA), the major histocompatibility complex in humans. HLA loci are known to be exceptionally diverse. As Apanius et al.  describe, only natural selection for heterozygosity can account for such a level of diversity.
Although the number of rare variants in relation to the number of total variants or segregating sites is not a measure that is generally used for case-control rare variant association analysis, Bansal et al.  pointed out that summary group-level statistics such as this can potentially be used along with individual-based measures. As they pointed out, the use and power of such statistics have not yet been assessed . One possible drawback of using group diversity measures in an association test is that population substructure within the group can inflate the statistic, as can be seen by the higher slope obtained for the pooled populations (see Figure 1). Controlling for this level of substructure would have to be considered in any method that relies on such measures.
The group-level rare to total variant ratio, which is the rare variant density measure investigated here for each population, can translate into differences in number of individuals who carry a rare variant and/or number of rare variants per individual, measures more commonly used in association analyses on rare variants . Two assumptions would have to hold for this translation: (1) The rare variant distribution across individuals does not differ between populations, and (2) the allele frequency spectrum for the rare SNPs does not differ between populations. Without testing these assumptions, we do see that the difference between the Yoruba and CEPH populations is also present for these measures (see Figure 3). Ancestry can therefore be an important confounder for rare variant association analysis in the same way it has proven to be for common SNP associations in genome-wide association studies. Simulations that study the best way to control for ancestry for rare variant association analysis still have to be performed. Admixed populations in particular may require a local level of ancestry control in order to account for differential rare variant densities throughout the genome.
This set of data does not afford much power for detecting significant values of Tajima’s D for individual genes, especially after accounting for multiple comparisons. Despite this, carrying out separate analyses on synonymous and nonsynonymous SNPs provides a way of seeing a result that can best be explained by selection. If random noise explained the rare variant distribution across the genome seen in this data set, then synonymous SNPs would necessarily present the same allele frequency spectrum as the nonsynonymous SNPs. Values of Tajima’s D for both sets of SNPs would not systematically differ. Here we see that they do; the nonsynonymous SNPs result in more negative values of Tajima’s D for all the populations (see Table 2). This may indicate an increase in power for detecting instances of selection across the genome when using the nonsynonymous SNPs, which are more likely to have a functional effect relative to the synonymous SNPs. If overall there are more instances of positive selection (negative Tajima’s D) than of balancing selection (positive Tajima’s D), then the increase in power would result in the more negative mean value of Tajima’s D for the population. This result is therefore a good indication that the nonsynonymous SNP analysis of Tajima’s D is picking up real signals of selection that are present in these data.
The contrast between the synonymous and nonsynonymous SNPs rare to total variant regressions (see Figure 2) also serves to distinguish whether selection or drift is accounting for the results. The observed population slope differences are likely caused by phenomena that affect the genome as a whole, such as genetic drift. It is to be expected, therefore, that because synonymous SNPs are less sensitive to functional variation across the genome, they can provide greater power for detecting these genome-wide differences caused by drift.
In this study we focus on the results for positive selection (excess of rare variants, negative values of Tajima’s D) rather than for balancing selection (excess of common variants, positive values of Tajima’s D) because of the ascertainment bias that is present in the data. The SNP discovery process presents a bias toward common SNPs that has not been corrected for , making any inference on positive values of Tajima’s D extremely difficult. Also, positive selection is likely to play a larger role across the genome than balancing selection would. Despite this, the rare variant to total variant regressions present an alternative to biased values of Tajima’s D for inferring balancing selection. The outliers under the regression line clearly show an excess of common variants that cannot be explained by ascertainment bias.
Finally, values of Tajima’s D provided by the nonsynonymous SNP analysis should provide relatively low variation across populations if this analysis is indeed improving the detection of functionally important genes. It is a biology that is likely to translate across different populations, and therefore the same genes should present the more extreme values from population to population. For the synonymous SNPs, on the other hand, genes are more likely to present extreme values by chance alone, and more variation across populations should be expected. This is in fact what we see here, and it serves as another indication that the nonsynonymous SNP analysis is picking up on real selection signal rather than random noise.
If this is the case, we can use our analysis to compare selection signals and what may be functionality across populations. Table 2 shows that most genes that may be presenting a selection signal have consistently highly negative values of Tajima’s D across all populations. One exception to this rule is RANBP2. RANBP2, like AHNAK, is a highly conserved gene. Its insufficiency has been linked to autosomal dominant necrotizing encephalopathy, among other things . Not only is there evidence for selection for the gene in itself, but the gene has also been the object of extensive duplication in the human lineage, with the resulting region occupying approximately 10% of chromosome 2 . There are eight partial copies of RANBP2 within this region. This gene family has been named RGP (RanBP2-like, GRIP domain containing proteins) . Evidence suggests that all eight copies are evolutionarily active and are expressed . This includes RGPD4, the other gene in this study that showed the same pattern as RANBP2.
Several possibilities can account for the striking difference between the rare variant load for the Luhya population compared to the rest of the populations for these RGPD4 and RANBP2. Environmental differences can certainly account for differences in selection pressure between populations even when the biology and functionality of the gene remains unchanged from population to population. On the other hand, the gene’s functionality itself may be different. Genomic context, which plays a role in the functionality of individual genes, can be greatly divergent between populations because of drift and other historical events, such as deletions and duplications. This result points out a specific instance in which it may be important to take into account the ancestral composition of the study population when attempting to narrow down genomic searches according to functionality. It also underlines the potential for disease heterogeneity across different populations.
Rare variant density differences exist between populations because of differences in their demographic histories and selection pressures. These differences have implications for conducting rare variant association analyses and for studies that attempt to use functionality as a means of delimiting the genomic search space for associations. They also bring to light the potential for disease heterogeneity across different populations.
This study was born out of the stimulating discussions held with Robert Elston and Xiaofeng Zhu and their colleagues in the Department of Epidemiology and Biostatistics at Case Western Reserve University. It was supported through a Computational Genomic Epidemiology of Cancer (CoGEC) grant, of which Robert Elston and Li Li are co-directors. The Genetic Analysis Workshop is supported by National Institutes of Health grant R01 GM031575. Dr. Zhu is supported by National Institutes of Health grant R01 HG003054.
This article has been published as part of BMC Proceedings Volume 5 Supplement 9, 2011: Genetic Analysis Workshop 17. The full contents of the supplement are available online at http://www.biomedcentral.com/1753-6561/5?issue=S9.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.